Embecta Market Capitalization from 2010 to 2024
| EMBC Stock | USD 14.41 0.59 4.27% |
Check Embecta Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Embecta Corp's main balance sheet or income statement drivers, such as Tax Provision of 43.9 M, Depreciation And Amortization of 23.5 M or Interest Expense of 129.2 M, as well as many indicators such as Price To Sales Ratio of 0.84, Dividend Yield of 0.0181 or Days Sales Outstanding of 6.37. Embecta financial statements analysis is a perfect complement when working with Embecta Corp Valuation or Volatility modules.
Embecta | Market Capitalization |
Latest Embecta Corp's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Embecta Corp over the last few years. It is Embecta Corp's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Embecta Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 797.44 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Embecta Market Capitalization Regression Statistics
| Arithmetic Mean | 1,529,379,503 | |
| Geometric Mean | 1,503,502,194 | |
| Coefficient Of Variation | 16.70 | |
| Mean Deviation | 181,189,378 | |
| Median | 1,642,622,864 | |
| Standard Deviation | 255,443,193 | |
| Sample Variance | 65251.2T | |
| Range | 781.2M | |
| R-Value | (0.61) | |
| Mean Square Error | 44548.9T | |
| R-Squared | 0.37 | |
| Significance | 0.02 | |
| Slope | (34,557,462) | |
| Total Sum of Squares | 913517.1T |
Embecta Market Capitalization History
About Embecta Corp Financial Statements
Embecta Corp stakeholders use historical fundamental indicators, such as Embecta Corp's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Embecta Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Embecta Corp's assets and liabilities are reflected in the revenues and expenses on Embecta Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Embecta Corp. Please read more on our technical analysis and fundamental analysis pages.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Embecta Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Embecta Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Embecta Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Embecta Corp Stock:Check out the analysis of Embecta Corp Correlation against competitors. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Embecta Corp. If investors know Embecta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Embecta Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Dividend Share 0.6 | Earnings Share 1.2 | Revenue Per Share 19.438 | Quarterly Revenue Growth (0.05) |
The market value of Embecta Corp is measured differently than its book value, which is the value of Embecta that is recorded on the company's balance sheet. Investors also form their own opinion of Embecta Corp's value that differs from its market value or its book value, called intrinsic value, which is Embecta Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Embecta Corp's market value can be influenced by many factors that don't directly affect Embecta Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Embecta Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Embecta Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.